Towards a better use of scientific advice for developers of advanced therapies

Scientific advice (SA) is an important tool offered by regulators to help developers generate robust evidence on a medicine's benefits and risks. Drawing on accumulated experience and looking at the SA provided by the European Medicines Agency in 2018 to advanced therapy medicinal products orig...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavridou, Anna, Rogers, Dolca, Bonelli, Milton, Schiel, Anja, Hidalgo‐Simon, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Advanced Therapy Medicinal Products–Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247399/
https://www.ncbi.nlm.nih.gov/pubmed/33237580
http://dx.doi.org/10.1111/bcp.14672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247399/
https://www.ncbi.nlm.nih.gov/pubmed/33237580
http://dx.doi.org/10.1111/bcp.14672

Ejemplares similares